Evidence map›Paper›PMID 35133704›Full record

ArticleAngewandte Chemie (International ed. in English)2022

MOF-Hosted Enzymes for Continuous Flow Catalysis in Aqueous and Organic Solvents.

Raphael Greifenstein, Tim Ballweg, Tawheed Hashem, Eric Gottwald, David Achauer, Frank Kirschhöfer, Michael Nusser, Gerald Brenner-Weiß, Elaheh Sedghamiz, Wolfgang Wenzel and 5 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Biomineralization of Glucose Oxidase fromBioengineering (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. MOF-Hosted Enzymes for Continuous Flow Catalysis in Aqueous and Organic Solvents.Angewandte Chemie (International ed. in English) · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Raphael GreifensteinInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-8348-0008
Tim BallwegInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Tawheed HashemInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Eric GottwaldInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
David AchauerInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Frank KirschhöferInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Michael NusserInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Gerald Brenner-WeißInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Elaheh SedghamizInstitute of Nanotechnology, Karlsruhe Institute of Technology, Bld. 640, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Wolfgang WenzelInstitute of Nanotechnology, Karlsruhe Institute of Technology, Bld. 640, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Esther MittmannInstitute for Biological Interfaces 1, Karlsruhe Institute of Technology, Bld. 601, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0001-5642-1232
Kersten S RabeInstitute for Biological Interfaces 1, Karlsruhe Institute of Technology, Bld. 601, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0001-7909-8191
Christof M NiemeyerInstitute for Biological Interfaces 1, Karlsruhe Institute of Technology, Bld. 601, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-8837-081X
Matthias FranzrebInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Christof WöllInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Bld. 330, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0003-1078-3304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fully exploiting the potential of enzymes in cell-free biocatalysis requires stabilization of the catalytically active proteins and their integration into efficient reactor systems. Although in recent years initial steps towards the immobilization of such biomolecules in metal-organic frameworks (MOFs) have been taken, these demonstrations have been limited to batch experiments and to aqueous conditions. Here we demonstrate a MOF-based continuous flow enzyme reactor system, with high productivity and stability, which is also suitable for organic solvents. Under aqueous conditions, the stability of the enzyme was increased 30-fold, and the space-time yield exceeded that obtained with other enzyme immobilization strategies by an order of magnitude. Importantly, the infiltration of the proteins into the MOF did not require additional functionalization, thus allowing for time- and cost-efficient fabrication of the biocatalysts using label-free enzymes.

Indexed as

Enzymes, ImmobilizedMetal-Organic FrameworksBiocatalysisCatalysisEnzymesProteinsSolventsEnzymesEnzymes, ImmobilizedMetal-Organic FrameworksProteinsSolventsBiocatalysisContinuous ReactorsEnzymesImmobilizationMetal-Organic Frameworks

Identifiers

PMID35133704
PMCPMC9314721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.